Association of Primary Care Providers' Beliefs of Statins for Primary Prevention and Statin Prescription

Jeffrey D. Clough, Seth Martin, Ann Marie Navar, Li Lin, N. Chantelle Hardy, Ursula Rogers, Lesley H. Curtis

Research output: Contribution to journalArticle

Abstract

Background The 2013 American College of Cardiology/American Heart Association Cholesterol Treatment Guideline increased the number of primary prevention patients eligible for statin therapy, yet uptake of these guidelines has been modest. Little is known of how primary care provider ( PCP ) beliefs influence statin prescription. Methods and Results We surveyed 164 PCP s from a community-based North Carolina network in 2017 about statin therapy. We evaluated statin initiation among the PCP s' statin-eligible patients between 2014 and 2015 without a previous prescription. Seventy-two PCP s (43.9%) completed the survey. The median estimate of the relative risk reduction for high-intensity statins was 45% (interquartile range, 25%-50%). A minority of providers (27.8%) believed statins caused diabetes mellitus, and only 16.7% reported always/very often discussing this with patients. Most PCPs (97.2%) believed that statins cause myopathy, and 72.3% reported always/very often discussing this with patients. Most (77.7%) reported always/very often using the 10-year atherosclerotic cardiovascular disease risk calculator, although many reported that in most cases other risk factors or patient preferences influenced prescribing (59.8% and 43.1%, respectively). Of 6172 statin-eligible patients, 22.3% received a prescription for a moderate- or high-intensity statin at follow-up. Providers reporting greater reliance on risk factors beyond atherosclerotic cardiovascular disease risk were less likely to prescribe statins. Conclusions Although beliefs and approaches to statin discussions vary among community PCP s, new prescription rates are low and minimally associated with those beliefs. These results highlight the complexity of increasing statin prescriptions for primary prevention and suggest that strategies to facilitate standardized discussions and to address external influences on patient beliefs warrant future study.

Original languageEnglish (US)
Pages (from-to)e010241
JournalJournal of the American Heart Association
Volume8
Issue number3
DOIs
StatePublished - Feb 5 2019

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Primary Prevention
Prescriptions
Primary Health Care
Cardiovascular Diseases
Guidelines
Patient Preference
Muscular Diseases
Risk Reduction Behavior

Keywords

  • guideline adherence
  • prevention
  • shared decision making
  • statin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Association of Primary Care Providers' Beliefs of Statins for Primary Prevention and Statin Prescription. / Clough, Jeffrey D.; Martin, Seth; Navar, Ann Marie; Lin, Li; Hardy, N. Chantelle; Rogers, Ursula; Curtis, Lesley H.

In: Journal of the American Heart Association, Vol. 8, No. 3, 05.02.2019, p. e010241.

Research output: Contribution to journalArticle

Clough, Jeffrey D. ; Martin, Seth ; Navar, Ann Marie ; Lin, Li ; Hardy, N. Chantelle ; Rogers, Ursula ; Curtis, Lesley H. / Association of Primary Care Providers' Beliefs of Statins for Primary Prevention and Statin Prescription. In: Journal of the American Heart Association. 2019 ; Vol. 8, No. 3. pp. e010241.
@article{4847bb24d29c4c7b81b6dfda59387cc4,
title = "Association of Primary Care Providers' Beliefs of Statins for Primary Prevention and Statin Prescription",
abstract = "Background The 2013 American College of Cardiology/American Heart Association Cholesterol Treatment Guideline increased the number of primary prevention patients eligible for statin therapy, yet uptake of these guidelines has been modest. Little is known of how primary care provider ( PCP ) beliefs influence statin prescription. Methods and Results We surveyed 164 PCP s from a community-based North Carolina network in 2017 about statin therapy. We evaluated statin initiation among the PCP s' statin-eligible patients between 2014 and 2015 without a previous prescription. Seventy-two PCP s (43.9{\%}) completed the survey. The median estimate of the relative risk reduction for high-intensity statins was 45{\%} (interquartile range, 25{\%}-50{\%}). A minority of providers (27.8{\%}) believed statins caused diabetes mellitus, and only 16.7{\%} reported always/very often discussing this with patients. Most PCPs (97.2{\%}) believed that statins cause myopathy, and 72.3{\%} reported always/very often discussing this with patients. Most (77.7{\%}) reported always/very often using the 10-year atherosclerotic cardiovascular disease risk calculator, although many reported that in most cases other risk factors or patient preferences influenced prescribing (59.8{\%} and 43.1{\%}, respectively). Of 6172 statin-eligible patients, 22.3{\%} received a prescription for a moderate- or high-intensity statin at follow-up. Providers reporting greater reliance on risk factors beyond atherosclerotic cardiovascular disease risk were less likely to prescribe statins. Conclusions Although beliefs and approaches to statin discussions vary among community PCP s, new prescription rates are low and minimally associated with those beliefs. These results highlight the complexity of increasing statin prescriptions for primary prevention and suggest that strategies to facilitate standardized discussions and to address external influences on patient beliefs warrant future study.",
keywords = "guideline adherence, prevention, shared decision making, statin",
author = "Clough, {Jeffrey D.} and Seth Martin and Navar, {Ann Marie} and Li Lin and Hardy, {N. Chantelle} and Ursula Rogers and Curtis, {Lesley H.}",
year = "2019",
month = "2",
day = "5",
doi = "10.1161/JAHA.118.010241",
language = "English (US)",
volume = "8",
pages = "e010241",
journal = "Journal of the American Heart Association",
issn = "2047-9980",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Association of Primary Care Providers' Beliefs of Statins for Primary Prevention and Statin Prescription

AU - Clough, Jeffrey D.

AU - Martin, Seth

AU - Navar, Ann Marie

AU - Lin, Li

AU - Hardy, N. Chantelle

AU - Rogers, Ursula

AU - Curtis, Lesley H.

PY - 2019/2/5

Y1 - 2019/2/5

N2 - Background The 2013 American College of Cardiology/American Heart Association Cholesterol Treatment Guideline increased the number of primary prevention patients eligible for statin therapy, yet uptake of these guidelines has been modest. Little is known of how primary care provider ( PCP ) beliefs influence statin prescription. Methods and Results We surveyed 164 PCP s from a community-based North Carolina network in 2017 about statin therapy. We evaluated statin initiation among the PCP s' statin-eligible patients between 2014 and 2015 without a previous prescription. Seventy-two PCP s (43.9%) completed the survey. The median estimate of the relative risk reduction for high-intensity statins was 45% (interquartile range, 25%-50%). A minority of providers (27.8%) believed statins caused diabetes mellitus, and only 16.7% reported always/very often discussing this with patients. Most PCPs (97.2%) believed that statins cause myopathy, and 72.3% reported always/very often discussing this with patients. Most (77.7%) reported always/very often using the 10-year atherosclerotic cardiovascular disease risk calculator, although many reported that in most cases other risk factors or patient preferences influenced prescribing (59.8% and 43.1%, respectively). Of 6172 statin-eligible patients, 22.3% received a prescription for a moderate- or high-intensity statin at follow-up. Providers reporting greater reliance on risk factors beyond atherosclerotic cardiovascular disease risk were less likely to prescribe statins. Conclusions Although beliefs and approaches to statin discussions vary among community PCP s, new prescription rates are low and minimally associated with those beliefs. These results highlight the complexity of increasing statin prescriptions for primary prevention and suggest that strategies to facilitate standardized discussions and to address external influences on patient beliefs warrant future study.

AB - Background The 2013 American College of Cardiology/American Heart Association Cholesterol Treatment Guideline increased the number of primary prevention patients eligible for statin therapy, yet uptake of these guidelines has been modest. Little is known of how primary care provider ( PCP ) beliefs influence statin prescription. Methods and Results We surveyed 164 PCP s from a community-based North Carolina network in 2017 about statin therapy. We evaluated statin initiation among the PCP s' statin-eligible patients between 2014 and 2015 without a previous prescription. Seventy-two PCP s (43.9%) completed the survey. The median estimate of the relative risk reduction for high-intensity statins was 45% (interquartile range, 25%-50%). A minority of providers (27.8%) believed statins caused diabetes mellitus, and only 16.7% reported always/very often discussing this with patients. Most PCPs (97.2%) believed that statins cause myopathy, and 72.3% reported always/very often discussing this with patients. Most (77.7%) reported always/very often using the 10-year atherosclerotic cardiovascular disease risk calculator, although many reported that in most cases other risk factors or patient preferences influenced prescribing (59.8% and 43.1%, respectively). Of 6172 statin-eligible patients, 22.3% received a prescription for a moderate- or high-intensity statin at follow-up. Providers reporting greater reliance on risk factors beyond atherosclerotic cardiovascular disease risk were less likely to prescribe statins. Conclusions Although beliefs and approaches to statin discussions vary among community PCP s, new prescription rates are low and minimally associated with those beliefs. These results highlight the complexity of increasing statin prescriptions for primary prevention and suggest that strategies to facilitate standardized discussions and to address external influences on patient beliefs warrant future study.

KW - guideline adherence

KW - prevention

KW - shared decision making

KW - statin

UR - http://www.scopus.com/inward/record.url?scp=85060549340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060549340&partnerID=8YFLogxK

U2 - 10.1161/JAHA.118.010241

DO - 10.1161/JAHA.118.010241

M3 - Article

C2 - 30681391

AN - SCOPUS:85060549340

VL - 8

SP - e010241

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

SN - 2047-9980

IS - 3

ER -